Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 156

Results For "US"

7178 News Found

Cambrex completes large-scale US API expansion
Biotech | April 12, 2022

Cambrex completes large-scale US API expansion

The expansion positions Cambrex with the largest and most advanced API facility in the United States


New very-high-sensitivity rapid antigen test kits hit Australian market
News | April 11, 2022

New very-high-sensitivity rapid antigen test kits hit Australian market

New Covid-19 Medriva Rapid Antigen Test kits with very high- sensitivity now available in Australia


Amyris commissions industry-leading fermentation plant
Biotech | April 11, 2022

Amyris commissions industry-leading fermentation plant

The site consists of five fermentation "mini-factories" capable of concurrently producing our more than 13 currently scaled and future bio-fermented products


Ministry of Ayush to organise two-day convention on World Homeopathy day
News | April 09, 2022

Ministry of Ayush to organise two-day convention on World Homeopathy day

World Homoeopathy Day is observed to commemorate the birth anniversary of the founder of Homoeopathy, Dr. Christian Fredrich Samuel Hahnemann to mark his 267th birth anniversary


Knowledge Centre for Pharmaceutical Continuous Manufacturing
Biotech | April 08, 2022

Knowledge Centre for Pharmaceutical Continuous Manufacturing

Although PCM has advanced substantially in recent years, most of the valuable technical information resides with private companies and academic publications across multiple platforms


Henlius' Serplulimab granted Orphan-Drug Designation for Small Cell Lung Cancer
Biotech | April 08, 2022

Henlius' Serplulimab granted Orphan-Drug Designation for Small Cell Lung Cancer

The company plans to file its NDA in China and MAA in the EU in 2022, making Hansizhuang potentially to be the world's first PD-1 inhibitor for the first-line treatment of SCLC


CDMOs shifting focus to meet future demand
News | April 07, 2022

CDMOs shifting focus to meet future demand

An integrated and agile approach enables the pharmaceutical CDMO industry to simplify manufacturing as it moves from primary care medicines to specialty medicines


Alembic gets USFDA tentative approval for dabigatran etexilate capsules
Drug Approval | April 07, 2022

Alembic gets USFDA tentative approval for dabigatran etexilate capsules

The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Pradaxa Capsules of Boehringer lngelheim


ENTOD Pharma bullish on Macushield sales
News | April 06, 2022

ENTOD Pharma bullish on Macushield sales

Macushield tablets assist with age-related macular degeneration, diabetic retinopathy and improves overall vision


Hataali wins US patent for the use of blockchain in advanced medicinal therapy
Digitisation | April 06, 2022

Hataali wins US patent for the use of blockchain in advanced medicinal therapy

The Blockchain-based solution was awarded the 2021 Bionow Technical Service Award